Download PDF
Homœopathic Links 2025; 38(04): 193-198
DOI: 10.1055/s-0043-1774323
Case Report

Plantar Psoriasis Treated with Individualised Homoeopathic Medicine – A Case Report

Authors

  • Indu Shukla

    1   Dr. D. P. Rastogi Central Research Institute for Homoeopathy, Noida, Uttar Pradesh, India

  • Priya Bansal

    2   Private Practitioner, Homoeopathy, India
Further Information
   Permissions and Reprints

Abstract

Psoriasis is a common non-infectious disease that is considered a chronic autoimmune condition. It is T-cell mediated and characterized by the rapid replacement of epidermal cells on the basal membrane level. Affecting approximately 2 to 3% of the population, around 3 to 4% of individuals with psoriasis experience palmoplantar psoriasis. This type of psoriasis can manifest at any age. Psoriasis, being a chronic skin disorder, impacts various aspects of an individual's social life. Homoeopathy has demonstrated positive outcomes in treating skin complaints. In this presentation, we discuss a diagnosed case of plantar psoriasis that was managed with individualized homoeopathic medicine. The patient exhibited itching eruptions on both soles, characterized by chronic local dryness, hardness, cracking, and roughness, without any other accompanying systemic complaints. This condition was treated using individualized homoeopathic medicine. The patient displayed significant improvement with the prescribed medicine, achieving full recovery within 6 months. The treatment comprised two doses of Sulphur 30 at a 1-month interval, followed by one dose of Sulphur 200 at a 4-month interval. Notably, there was no relapse for over 2 years, indicating that the benefits of the therapy persisted long after the treatment concluded. An assessment of possible causal attribution was conducted using the Modified Naranjo Criteria (Score-7 out of 13). Photographic documentation was conducted at the beginning and conclusion of the treatment. The negative impact of this chronic condition on the patients' quality of life was evaluated through the Dermatology Life Quality Index and was significantly improved with homoeopathic treatment.

Keywords

palmoplantar - individualised homoeopathy - sulphur

Patients' Consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published, and due efforts will be made to conceal his identity, but anonymity cannot be guaranteed.


Editor's Note

Patients with psoriasis demonstrate a markedly higher prevalence of cardiovascular risk factors and appear to be at increased risk for ischemic heart disease, cerebrovascular disease, and peripheral arterial disease. This growing recognition of the dermatovascular connection highlights that psoriasis is not merely a cutaneous disorder but part of a broader systemic inflammatory process that also predisposes individuals to peripheral vascular disease. Understanding these overlapping pathways is essential for clinicians and researchers, as it opens new avenues for early vascular risk assessment, integrated patient management, and innovative therapeutic approaches—including contributions from homoeopathic research aimed at addressing systemic inflammation and vascular dysfunction.


Psoriasis is increasingly regarded as a systemic inflammatory disorder with clinically relevant vascular implications. Large population-based cohort studies consistently demonstrate that individuals with psoriasis have a higher prevalence of cardiovascular risk factors and an elevated incidence of ischemic heart disease, cerebrovascular disease, and peripheral arterial disease. Meta-analytic data involving more than twelve million participants indicate a significant association between psoriasis and the development of peripheral vascular disease, suggesting that vascular involvement extends beyond traditional atherosclerotic risk profiles. Genetic and Mendelian-randomization studies further support a potential causal relationship between psoriatic inflammation and coronary artery disease, while vascular imaging research shows that suppression of IL-23/IL-17–driven inflammatory pathways through targeted therapy may improve arterial stiffness and reduce subclinical atherosclerosis. These findings collectively reinforce the evolving concept that psoriasis is not confined to the skin but contributes to systemic vascular dysfunction, warranting integrated clinical assessment and early risk-factor modification.


Psoriasis stands out as a model condition illustrating how skin inflammation can mirror vascular risk, prompting deeper cardiovascular assessment, including screening for peripheral vascular disease.


Supplementary Material



Publication History

Article published online:
06 October 2023

© 2023. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India